Cambria Cannabis ETF (TOKE)
| Assets | $13.59M |
| Expense Ratio | n/a |
| PE Ratio | n/a |
| Shares Out | 2.58M |
| Dividend (ttm) | $0.06 |
| Dividend Yield | 1.08% |
| Ex-Dividend Date | Dec 18, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 15.71% |
| Volume | 64,204 |
| Open | 5.19 |
| Previous Close | 5.20 |
| Day's Range | 5.15 - 5.24 |
| 52-Week Low | 4.06 |
| 52-Week High | 7.33 |
| Beta | 0.82 |
| Holdings | 26 |
| Inception Date | Jul 25, 2019 |
About TOKE
Cambria Cannabis ETF is a global, all-cap portfolio that has exposure to the broad cannabis industry. TOKE will target approximately 20 to 50 of the top cannabis companies around the world. Why TOKE?
Top 10 Holdings
98.11% of assets| Name | Symbol | Weight |
|---|---|---|
| First American Treasury Obligations Fund | FXFXX | 31.29% |
| OTHER ASSETS AND LIABILITIES | n/a | 20.85% |
| Village Farms International, Inc. | VFF | 8.49% |
| GREEN THUMB INDUSTRIES INC SWAP | n/a | 6.70% |
| Cronos Group Inc. | CRON | 5.56% |
| British American Tobacco p.l.c. | BATS | 5.30% |
| GLASS HOUSE BRANDS INC SWAP | n/a | 5.26% |
| Turning Point Brands, Inc. | TPB | 5.01% |
| Altria Group, Inc. | MO | 4.85% |
| Philip Morris International Inc. | PM | 4.81% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2025 | $0.02348 | Dec 19, 2025 |
| Sep 18, 2025 | $0.02166 | Sep 19, 2025 |
| Jun 18, 2025 | $0.01097 | Jun 20, 2025 |
| Dec 20, 2024 | $0.14305 | Dec 30, 2024 |
| Sep 20, 2024 | $0.08207 | Sep 30, 2024 |
| Jun 21, 2024 | $0.05207 | Jul 1, 2024 |
Performance
TOKE had a total return of 27.32% in the past year, including dividends. Since the fund's inception, the average annual return has been -18.14%.
News
Cambria Announces Liquidation of Cambria Cannabis ETF
MANHATTAN BEACH, Calif.--(BUSINESS WIRE)--Cambria Investment Management announced the scheduled liquidation of the Cambria Cannabis ETF (TOKE).
Road to Full Cannabis Legalization in the U.S.
Morgan Paxhia discusses the latest trends in the cannabis space. He talks about the road to full cannabis legalization in the U.S. He then goes over the best positioned cannabis stocks.
5 developments that cannabis investors did not expect in 2021
2021 has been an interesting year for cannabis investors with lots of positive and negative news. According to New Cannabis Ventures, following were the five developments that cannabis investors hadn'...
Pot plays and the presidency: What to expect from cannabis ETFs under Biden
Tim Seymour, chief investment officer of Seymour Asset Management and one of the brains behind the CNBS ETF, talks pot's prospects with CNBC's Bob Pisani.
Best Marijuana ETFs for Q4 2020
The best marijuana ETFs for Q4 2020 are YOLO, TOKE, and CNBS.
Here's how SPACs are changing the cannabis industry
Former Senate Majority Leader Tom Daschle and Kyler Detwiler, Clever Leaves CEO, join "Squawk Alley" to discuss cannabis regulation in the U.S. and pot stocks going public through SPACs.
3 Cannabis ETFs For 4/20
After a rough year in 2019 (to put it mildly), cannabis stocks and the related exchange-traded funds are incurring significant punishment again this year.
Cryptocurrency, cannabis and eco-conscious investing: What's ahead in 2020
Tom Lydon, CEO of ETF Trends, and Nick Colas, co-founder of DataTrek Research, talk 2020 prospects for bitcoin, cannabis and ESG with CNBC's Bob Pisani.
5 Worst ETFs Of 2019
It's been a great year for stocks. For gold, too. And plenty of corners of the bond market as well.